Axillary LNs Evalution in Breast Cancer by Multimodal Us
"Axillary Nodal Evaluation in Breast Cancer by Multimodal US"
1 other identifier
observational
30
0 countries
N/A
Brief Summary
The present study is designed to evaluate the role of simultaneous multi-modal sonographic tools-Ultrasound (US), Color Doppler Ultrasound (CDU), and Ultrasound Elastography (UE)-in determining the nature (benign or malignant) of axillary lymph nodes (ALNs) in patients with primary breast cancer. It aims to compare the diagnostic indices of each modality individually against their combined performance. Specifically, the study will assess whether adding UE to conventional gray-scale US and CDU improves diagnostic accuracy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2024
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2024
CompletedFirst Posted
Study publicly available on registry
November 19, 2024
CompletedStudy Start
First participant enrolled
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
November 19, 2024
November 1, 2024
2 years
November 5, 2024
November 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Evaluation of axillary LNs in Breast Cancer by Grey Scale Ultrasound
Evaluate axillary lymph nodes (LNs) in breast cancer patients using grey scale ultrasound to assess specific characteristics such as size, shape, and cortical thickening. Results will be compared to Fine Needle Aspiration Cytology (FNAC) or histopathology findings.
Baseline
Evaluation of axillary LNs in Breast Cancer by Color Doppler Ultrasound
Evaluate axillary lymph nodes (LNs) in breast cancer patients using color Doppler ultrasound to assess vascularity patterns. Results will be compared to FNAC or histopathology findings.
Baseline
Evaluation of axillary LNs in Breast Cancer by Elastography Ultrasound
Evaluate axillary lymph nodes (LNs) in breast cancer patients using elastography ultrasound to measure stiffness and elasticity. Results will be compared to FNAC or histopathology findings.
Baseline
Comparison of Multimodal Ultrasound Findings with Histopathology Results
Compare the findings from grey scale ultrasound, color Doppler ultrasound, and elastography ultrasound with histopathology results to assess diagnostic accuracy for evaluating axillary lymph nodes in breast cancer.
Baseline
Interventions
Greyscale US: grey scale ultrasound Color Doppler US: Color Doppler ultrasound Elastography US: Elastography ultrasound
Eligibility Criteria
Female patients with primary breast cancer and metastatic axillary LNs
You may qualify if:
- \- Patients with primary breast cancer (BrCa) and axillary lymph nodes (ALNs) referred to the Department of Diagnostic Radiology for pre-operative assessment of presence, extent and nature of ALNs.
You may not qualify if:
- Patients with secondary or recurrent Breast Ca
- Patients exposed to loco-regional radio- or chemotherapy
- Patients with previous axilla surgery
- ± Patients with confirmed metastatic tumor to bone, liver and/or lungs
- Patients who deny or refuse to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Tsai WC, Lin CK, Wei HK, Yu BL, Hung CF, Cheng SH, Chen CM. Sonographic elastography improves the sensitivity and specificity of axilla sampling in breast cancer: a prospective study. Ultrasound Med Biol. 2013 Jun;39(6):941-9. doi: 10.1016/j.ultrasmedbio.2012.12.013. Epub 2013 Mar 7.
PMID: 23465139BACKGROUNDDeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Breast cancer statistics, 2019. CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.
PMID: 31577379BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Abul Hassan H Mohammed, AP.radiology
Assiut University
- STUDY DIRECTOR
Sara M Ahmed, AP.radiology
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
November 5, 2024
First Posted
November 19, 2024
Study Start
November 20, 2024
Primary Completion (Estimated)
November 20, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
November 19, 2024
Record last verified: 2024-11